A functional signal profiling test for identifying a subset of HER2-negative breast cancers with abnormally amplified HER2 signaling activity. [electronic resource]
Producer: 20180220Description: 78577-78590 p. digitalISSN:- 1949-2553
- Adult
- Aged
- Antibodies, Monoclonal, Humanized -- pharmacology
- Antineoplastic Agents, Immunological -- pharmacology
- Biosensing Techniques
- Breast Neoplasms -- drug therapy
- Case-Control Studies
- Cell Adhesion -- drug effects
- Cell Line, Tumor
- Dose-Response Relationship, Drug
- Epidermal Growth Factor -- pharmacology
- Female
- Humans
- Middle Aged
- Receptor, ErbB-2 -- agonists
- Receptors, Estrogen -- metabolism
- Receptors, Progesterone -- metabolism
- Reproducibility of Results
- Signal Transduction -- drug effects
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.